Where oncologic and surgical complication scoring systems collide: Time for a new consensus for CRS/HIPEC

World Journal of Surgery

Volumn 40, Issue 5, 2016, Pages 1075-1081

  Lehmann, Kuno ^a   Eshmuminov, Dilmurodjon ^a   Slankamenac, Ksenija ^a   Kranzbühler, Benedict ^a   Clavien, Pierre Alain ^a   Vonlanthen, René ^a   Gertsch, Philippe ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; CLASSIFICATION; COMPARATIVE STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; REGIONAL PERFUSION; SEVERITY OF ILLNESS INDEX; SWITZERLAND; THERMOTHERAPY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; SWITZERLAND; YOUNG ADULT;

EID: 84949960823     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-015-3366-0     Document Type: Article

References (23)

1. Elias D, Gilly F, Boutitie F et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63-68
2. Elias D, Lefevre JH, Chevalier J et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27(681-68):5
3. Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363
4. Franko J, Shi Q, Goldman CD et al (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30:263-267
5. Chua TC, Yan TD, Saxena A et al (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249:900-907
6. Pelz JO, Germer CT (2013) Morbidity and mortality of hyperthermic intraperitoneal chemoperfusion. Der Chir Z fur alle Geb der Oper Med 84:957-961
7. Younan R, Kusamura S, Baratti D et al (2008) Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 98:253-257
8. Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176-181
9. Glockzin G, Rochon J, Arnold D et al (2013) A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial. BMC Cancer 13:67
10. Dindo D, Demartines N (2004) Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213
11. Sink EL, Leunig M, Zaltz I et al (2012) Reliability of a complication classification system for orthopaedic surgery. Clin Orthop Relat Res 470(2220-222):6
12. Permpongkosol S, Link RE, Su LM et al (2007) Complications of 2775 urological laparoscopic procedures: 1993-2005. J Urol 177:580-585
13. Clavien PA, Camargo CA Jr, Croxford R et al (1994) Definition and classification of negative outcomes in solid organ transplantation. Appl Liver Transpl Ann Surg 220:109-120
14. Jafari MD, Halabi WJ, Stamos MJ et al (2013) Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program JAMA Surgery
15. Kajdi ME, Beck-Schimmer B, Held U et al (2014) Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol 12:136
16. van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(2074-208):4
17. Nordlinger B, Sorbye H, Glimelius B et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14:1208-1215
18. Glehen O, Osinsky D, Cotte E et al (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863-869
19. CTCAE: Common Terminology Criteria for Adverse Events v3, Cancer Therapy Evaluation Program (CTEP), 2006
20. Clavien PA (2009) Strasberg SM severity grading of surgical complications. Ann Surg 250(197-19):8
21. Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(187-19):6
22. Haynes AB, Weiser TG, Berry WR et al (2009) A surgical safety checklist to reduce morbidity and mortality in a global population. New Engl J Med 360(491-49):9
23. Slankamenac K, Nederlof N, Pessaux P et al (2014) The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg 260:757-762 discussion 762-753